Linc AB (STO:LINC)

Market Cap	3.91B -0.4%
Revenue (ttm)	-414.00M
Net Income	-399.65M
EPS	-6.90
Shares Out	57.91M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	47,523
Average Volume	44,106
Open	65.00
Previous Close	67.50
Day's Range	65.00 - 69.90
52-Week Range	58.90 - 83.60
Beta	0.81
RSI	47.80
Earnings Date	Apr 21, 2026

About Linc AB

Linc AB is a private equity and venture capital firm, specializing in early and mature stage investments in pharmaceutical, life-science and med-tech companies. It prefers to invest in drug development usually take place at an early stage, while investments in medical technology are made in more mature businesses. The investments are made in both private and public companies and in research and operational companies. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million ($2.99 million) and SEK 250 million ($29.9...

• Industry: Asset Management
• Sector: Financials
• Founded: 1991
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LINC